Home > Insider Trading > Filing (0000200406-10-000091)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
200406	Johnson & Johnson	JNJ	Pharmaceutical Preparations (2834)	221024240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1142630	James Cullen	Johnson &Amp; Johnson One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common	Disposition	2010-09-17	20,000	$61.35	26,022	No	4	S	Direct
Common	Disposition	2010-09-17	10,000	$61.35	20,000	No	4	S	Indirect	By Family LP and Family Foundation

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	By Family LP and Family Foundation

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common	Phantom Stock Units	$0.00			0	30,443	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	0	30,443	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $61.35 to $61.3703. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes 745 shares held under Issuer's Dividend Reinvestment Plan.
The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
The Phantom Stock Units held under the Issuer's Non-Employee Director Deferred Fee Planare to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time.
1 for 1